<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57717">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02354677</url>
  </required_header>
  <id_info>
    <org_study_id>9244</org_study_id>
    <secondary_id>2013-A01405-40</secondary_id>
    <nct_id>NCT02354677</nct_id>
  </id_info>
  <brief_title>Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients</brief_title>
  <acronym>RRR</acronym>
  <official_title>Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      COPD is characterized by exagerated decline FEV1 related to obstructive non reversible
      airflow. This could be the consequence of structural changes and inflammatory pattern of the
      bronchial wall. Lesions could lead to normal but also abnormal remodeling specially in COPD
      including a decrease in Club cells number and function.There is no treatment actually
      available targeted to a normal repair of the epithelium. The objective of this work is to
      identify potential targets for reprograming bronchial epithelial cells I order to achieve a
      good repair.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 17, 2014</start_date>
  <completion_date type="Anticipated">October 17, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Full recovery one day after injury (yes / no) proportion of cells showing the repair, remodeling or regeneration of the epithelium (ciliated cells, mucus cells, Clara cells) in culture in air-liquid interface in the three groups</measure>
    <time_frame>1 day</time_frame>
    <description>The study will be judged on the proportion of cells showing the repair, remodeling or regeneration of the epithelium (ciliated cells, mucus cells, Clara cells) in culture in air-liquid interface in the three groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of apoptosis and inflammation (IL8)</measure>
    <time_frame>24 months</time_frame>
    <description>Determine the molecular mechanisms and deleterious cell leading to poor repair of the epithelium in patients with COPD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the effect of the CC10 protein secreted by Clara cells on the repair of the bronchial epithelium.</measure>
    <time_frame>24 months</time_frame>
    <description>Measuring the reprogramming of the epithelium of COPD patients to a control-type epithelium</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heathy Volunteers</condition>
  <condition>Smokers</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Heathy volunteers, smokers and COPD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In vitro experiments on bronchial epithelial cells</intervention_name>
    <arm_group_label>Heathy volunteers, smokers and COPD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        COPD - Smokers or ex smokers &gt; 30p/yr

          -  FEV1/FVC &lt; 0.7

          -  With a fibroscopy prescription

        Smokers - Smokers or ex smokers &gt; 30p/yr

          -  FEV1/FVC &gt; 0.7

          -  With a fibroscopy prescription

        Controls - age superior or equal to 18

          -  no smoker (for 5 years)

          -  with a fibroscopy prescription

        Exclusion Criteria:

          -  Xylocaine hypersensibility

          -  Porphyria

          -  severe hepatic failure

          -  Epilepsy

          -  Severe cardiac failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BOURDIN Aranud, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PETIT Aurélie, PhD</last_name>
    <phone>+33467042020</phone>
    <email>aurelie.fort@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>VACHIER Isabelle, MD, PhD</last_name>
    <phone>+33467042020</phone>
    <email>isabelle.vachier@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pneumology Department</name>
      <address>
        <city>Montpellier</city>
        <zip>30295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PETIT Aurélie, PhD</last_name>
      <phone>+33467042020</phone>
      <email>aurelie.fort@inserm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>January 12, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchial epithelium</keyword>
  <keyword>COPD</keyword>
  <keyword>Repair</keyword>
  <keyword>Remodelling</keyword>
  <keyword>Club Cells</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
